Form 13G SAB Biotherapeutics For: 14 November
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SAB Biotherapeutics Inc (SABS)
SAB Biotherapeutics Inc stock price live, this page displays NASDAQ SABS stock exchange data. View the SABS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SAB Biotherapeutics Inc real time stock price chart below.
What Is the SAB Biotherapeutics Inc Stock Price Today?
The SAB Biotherapeutics Inc stock price today is 3.700.
What Is the Stock Symbol for SAB Biotherapeutics Inc?
The stock symbol for SAB Biotherapeutics Inc is ""SABS.""
What Stock Exchange Does SAB Biotherapeutics Inc Trade On?
SAB Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is SAB Biotherapeutics Inc a Good Stock to Buy?
Determining whether SAB Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SABS quote. (ISIN: US78397T2024)
What Is the SAB Biotherapeutics Inc Stock Price Today?
The SAB Biotherapeutics Inc stock price today is 3.700.
What Is the Stock Symbol for SAB Biotherapeutics Inc?
The stock symbol for SAB Biotherapeutics Inc is ""SABS.""
What Stock Exchange Does SAB Biotherapeutics Inc Trade On?
SAB Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is SAB Biotherapeutics Inc a Good Stock to Buy?
Determining whether SAB Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SABS quote. (ISIN: US78397T2024)
NASDAQ
Currency in USD
Fair Value
An estimate of a SAB Biotherapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.580
3.783
52 wk Range
1.000
6.600
SABS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a SAB Biotherapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.5803.783
52 wk Range
1.0006.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SABS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a SAB Biotherapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
8.833
Upside
+138.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
SAB Biotherapeutics Inc Company Profile
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
Compare SABS to Peers and Sector
Metrics to compare | SABS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSABSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −41.1x | −3.9x | −0.6x | |
PEG Ratio | −0.70 | 0.45 | 0.00 | |
Price/Book | 1.1x | 4.3x | 2.6x | |
Price / LTM Sales | 1,535.7x | 67.5x | 3.3x | |
Upside (Analyst Target) | 120.4% | 76.8% | 41.4% | |
Fair Value Upside | Unlock | −4.1% | 6.0% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.833
(+138.74% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-0.21 / -0.12
Revenue / Forecast
-- / 210.00K
People Also Watch
FAQ
What Is the SAB Biotherapeutics (SABS) Premarket Price Today?
The SAB Biotherapeutics (SABS) premarket price is 3.630. Premarket price change units: -0.010. Premarket percentage change: -0.270%. Premarket volume: 480.000. Current date: 04 Dec 2025. Previous close: 3.640
What Stock Exchange Does SAB Biotherapeutics Trade On?
SAB Biotherapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for SAB Biotherapeutics?
The stock symbol for SAB Biotherapeutics is "SABS."
What Is the SAB Biotherapeutics (SABS) Afterhours Price Today? (Afterhours variable test: 3.698) Current Date: 04 Dec 2025
After hours price: 3.698. After hours price change (units): -0.002. Price change percentage: -0.050%
What Is the SAB Biotherapeutics Market Cap?
As of today, SAB Biotherapeutics market cap is 176.15M.
What Is SAB Biotherapeutics's Earnings Per Share (TTM)?
The SAB Biotherapeutics EPS (TTM) is -2.23.
From a Technical Analysis Perspective, Is SABS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has SAB Biotherapeutics Stock Split?
SAB Biotherapeutics has split 1 times.
How Many Employees Does SAB Biotherapeutics Have?
SAB Biotherapeutics has 63 employees.
What is the current trading status of SAB Biotherapeutics (SABS)?
As of 04 Dec 2025, SAB Biotherapeutics (SABS) is trading at a price of 3.700, with a previous close of 3.640. The stock has fluctuated within a day range of 3.580 to 3.783, while its 52-week range spans from 1.000 to 6.600.
What Is SAB Biotherapeutics (SABS) Price Target According to Analysts?
The average 12-month price target for SAB Biotherapeutics is USD8.83333, with a high estimate of USD14 and a low estimate of USD5. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +138.74% Upside potential.
What Is the SABS Premarket Price?
SABS's last pre-market stock price is 3.630. The pre-market share volume is 480.000, and the stock has decreased by -0.010, or -0.270%.
What Is the SABS After Hours Price?
SABS's last after hours stock price is 3.698, the stock has decreased by -0.002, or -0.050%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.